A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects

Condition:   Prostate Cancer Interventions:   Drug: SOL-804-F;   Drug: Zytiga Sponsors:   Bukwang Pharmaceutical;   Dyna Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials